Recent studies in patients suffering from acromegaly, a clinical syndrome caused by increased concentrations of growth hormone (GH) and insulin-like growth factor 1 (IGF-I), reported very low levels of intrahepatic lipids (IHLs) compared with healthy controls, even though they present with pronounced insulin resistance (2, 3). The gene discussed is GH1; the disease is acromegaly.